351 related articles for article (PubMed ID: 27861742)
1. Megakaryocytes from CYCS mutation-associated thrombocytopenia release platelets by both proplatelet-dependent and -independent processes.
Ong L; Morison IM; Ledgerwood EC
Br J Haematol; 2017 Jan; 176(2):268-279. PubMed ID: 27861742
[TBL] [Abstract][Full Text] [Related]
2. Megakaryocytes of patients with MYH9-related thrombocytopenia present an altered proplatelet formation.
Pecci A; Malara A; Badalucco S; Bozzi V; Torti M; Balduini CL; Balduini A
Thromb Haemost; 2009 Jul; 102(1):90-6. PubMed ID: 19572073
[TBL] [Abstract][Full Text] [Related]
3. Congenital thrombocytopenia and cytochrome C mutation: a matter of birth and death.
Cramer Bordé E; Ouzegdouh Y; Ledgerwood EC; Morison IM
Semin Thromb Hemost; 2011 Sep; 37(6):664-72. PubMed ID: 22102269
[TBL] [Abstract][Full Text] [Related]
4. Mechanisms of thrombocytopenia in platelet-type von Willebrand disease.
Bury L; Malara A; Momi S; Petito E; Balduini A; Gresele P
Haematologica; 2019 Jul; 104(7):1473-1481. PubMed ID: 30655369
[TBL] [Abstract][Full Text] [Related]
5. ADAP deficiency impairs megakaryocyte polarization with ectopic proplatelet release and causes microthrombocytopenia.
Spindler M; van Eeuwijk JMM; Schurr Y; Nurden P; Nieswandt B; Stegner D; Reinhold A; Bender M
Blood; 2018 Aug; 132(6):635-646. PubMed ID: 29950291
[TBL] [Abstract][Full Text] [Related]
6. [Diagnostic significance of the number of bone marrow megakaryocytes in cases with decreased platelet production evidenced by platelet kinetic study].
Tsukada T; Ueyama J; Miyakoshi S; Morinaga S; Mutoh Y; Yamaguchi H; Matsuya S
Rinsho Ketsueki; 1990 Jul; 31(7):903-10. PubMed ID: 2214187
[TBL] [Abstract][Full Text] [Related]
7. A dominant-negative GFI1B mutation in the gray platelet syndrome.
Monteferrario D; Bolar NA; Marneth AE; Hebeda KM; Bergevoet SM; Veenstra H; Laros-van Gorkom BA; MacKenzie MA; Khandanpour C; Botezatu L; Fransen E; Van Camp G; Duijnhouwer AL; Salemink S; Willemsen B; Huls G; Preijers F; Van Heerde W; Jansen JH; Kempers MJ; Loeys BL; Van Laer L; Van der Reijden BA
N Engl J Med; 2014 Jan; 370(3):245-53. PubMed ID: 24325358
[TBL] [Abstract][Full Text] [Related]
8. TUBB1 mutation disrupting microtubule assembly impairs proplatelet formation and results in congenital macrothrombocytopenia.
Kunishima S; Nishimura S; Suzuki H; Imaizumi M; Saito H
Eur J Haematol; 2014 Apr; 92(4):276-82. PubMed ID: 24344610
[TBL] [Abstract][Full Text] [Related]
9. Hypercholesterolemia impairs megakaryopoiesis and platelet production in scavenger receptor BI knockout mice.
Ouweneel AB; Hoekstra M; van der Wel EJ; Schaftenaar FH; Snip OSC; Hassan J; Korporaal SJA; Van Eck M
Atherosclerosis; 2019 Mar; 282():176-182. PubMed ID: 30278990
[TBL] [Abstract][Full Text] [Related]
10. Platelet demand modulates the type of intravascular protrusion of megakaryocytes in bone marrow.
Kowata S; Isogai S; Murai K; Ito S; Tohyama K; Ema M; Hitomi J; Ishida Y
Thromb Haemost; 2014 Oct; 112(4):743-56. PubMed ID: 24965909
[TBL] [Abstract][Full Text] [Related]
11. Mutations of cytochrome c identified in patients with thrombocytopenia THC4 affect both apoptosis and cellular bioenergetics.
De Rocco D; Cerqua C; Goffrini P; Russo G; Pastore A; Meloni F; Nicchia E; Moraes CT; Pecci A; Salviati L; Savoia A
Biochim Biophys Acta; 2014 Feb; 1842(2):269-74. PubMed ID: 24326104
[TBL] [Abstract][Full Text] [Related]
12. Sustained thrombocytopenia in mice: serial studies of megakaryocytes and platelets.
Stenberg PE; Levin J; Corash L
Exp Hematol; 1990 Feb; 18(2):124-32. PubMed ID: 2303104
[TBL] [Abstract][Full Text] [Related]
13. Type 2B von Willebrand disease associated with the release of platelet agglutinates from megakaryocytes in the bone marrow.
Slayton WB; Patel M; Sola-Visner M; Harris N; Rivers A; Montgomery RR; Friedman KD
J Pediatr Hematol Oncol; 2008 Sep; 30(9):708-11. PubMed ID: 18776767
[TBL] [Abstract][Full Text] [Related]
14. Megakaryocytes and inherited thrombocytopenias.
Bellucci S
Baillieres Clin Haematol; 1997 Feb; 10(1):149-62. PubMed ID: 9154320
[TBL] [Abstract][Full Text] [Related]
15. The Y49H cytochrome c variant enhances megakaryocytic maturation of K-562 cells.
Shafaei Pishabad Z; Ledgerwood EC
Biochim Biophys Acta Mol Basis Dis; 2024 Jun; 1870(5):167134. PubMed ID: 38531481
[TBL] [Abstract][Full Text] [Related]
16. Deficiency in the Wiskott-Aldrich protein induces premature proplatelet formation and platelet production in the bone marrow compartment.
Sabri S; Foudi A; Boukour S; Franc B; Charrier S; Jandrot-Perrus M; Farndale RW; Jalil A; Blundell MP; Cramer EM; Louache F; Debili N; Thrasher AJ; Vainchenker W
Blood; 2006 Jul; 108(1):134-40. PubMed ID: 16522820
[TBL] [Abstract][Full Text] [Related]
17. Pak2 restrains endomitosis during megakaryopoiesis and alters cytoskeleton organization.
Kosoff RE; Aslan JE; Kostyak JC; Dulaimi E; Chow HY; Prudnikova TY; Radu M; Kunapuli SP; McCarty OJ; Chernoff J
Blood; 2015 May; 125(19):2995-3005. PubMed ID: 25824689
[TBL] [Abstract][Full Text] [Related]
18. A mutation of human cytochrome c enhances the intrinsic apoptotic pathway but causes only thrombocytopenia.
Morison IM; Cramer Bordé EM; Cheesman EJ; Cheong PL; Holyoake AJ; Fichelson S; Weeks RJ; Lo A; Davies SM; Wilbanks SM; Fagerlund RD; Ludgate MW; da Silva Tatley FM; Coker MS; Bockett NA; Hughes G; Pippig DA; Smith MP; Capron C; Ledgerwood EC
Nat Genet; 2008 Apr; 40(4):387-9. PubMed ID: 18345000
[TBL] [Abstract][Full Text] [Related]
19. Mice lacking transcription factor NF-E2 provide in vivo validation of the proplatelet model of thrombocytopoiesis and show a platelet production defect that is intrinsic to megakaryocytes.
Lecine P; Villeval JL; Vyas P; Swencki B; Xu Y; Shivdasani RA
Blood; 1998 Sep; 92(5):1608-16. PubMed ID: 9716588
[TBL] [Abstract][Full Text] [Related]
20. Immune thrombocytopenia: antiplatelet autoantibodies inhibit proplatelet formation by megakaryocytes and impair platelet production in vitro.
Iraqi M; Perdomo J; Yan F; Choi PY; Chong BH
Haematologica; 2015 May; 100(5):623-32. PubMed ID: 25682608
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
